Ubs Asset Management Americas Inc Bio Rad Laboratories, Inc. Transaction History
Ubs Asset Management Americas Inc
- $477 Billion
- Q2 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 16,749 shares of BIO stock, worth $4.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,749
Previous 382,807
95.62%
Holding current value
$4.6 Million
Previous $93.2 Million
95.67%
% of portfolio
0.0%
Previous 0.02%
Shares
31 transactions
Others Institutions Holding BIO
# of Institutions
427Shares Held
19.1MCall Options Held
10.7KPut Options Held
37.5K-
First Eagle Investment Management, LLC2.52MShares$692 Million1.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.85MShares$507 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$426 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1MShares$275 Million0.06% of portfolio
-
Veritas Asset Management LLP863KShares$237 Million2.27% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $6.77B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...